Metformin, the remarkable and unique antidiabetic agent

In the current issue of this Journal, Fiad and colleagues thoughtfully reviewed in detail the role of metformin in current clinical practice and highlighted the additional effects of metformin independent of the glycemic action of the drug. The review is comprehensive, up to date and is extensively supported by the literature. Metformin remains the first drug of choice in patients diagnosed with type 2 diabetes. Its vascular protection actions are particularly interesting though not yet fully understood. Its antineoplastic actions are very exciting. The authors clarify the issues of gastrointestinal side effects and renal limitations of its use and give practical ways of minimizing the potential loss of benefit to all treated patients.

Standort
Deutsche Nationalbibliothek Frankfurt am Main
Umfang
Online-Ressource
Sprache
Englisch

Erschienen in
Metformin, the remarkable and unique antidiabetic agent ; volume:05 ; number:04 ; year:2013 ; pages:240-242
Ibnosina journal of medicine and biomedical sciences ; 05, Heft 04 (2013), 240-242

Beteiligte Personen und Organisationen
Lakhdar, Abdulfattah

DOI
10.4103/1947-489X.210551
URN
urn:nbn:de:101:1-2022101002333403132590
Rechteinformation
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
Letzte Aktualisierung
15.08.2025, 07:26 MESZ

Datenpartner

Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.

Beteiligte

  • Lakhdar, Abdulfattah

Ähnliche Objekte (12)